Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor

Journal of Virology

Volumn 75, Issue 18, 2001, Pages 8605-8614

  Derdeyn, C A ^a   Decker, J M ^a   Sfakianos, J N ^a   Zhang, Z ^a   O'Brien, W A ^a   Ratner, L ^a   Shaw, G M ^a   Hunter, E ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; ENFUVIRTIDE; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; INHIBITOR PROTEIN; RECEPTOR; T 649; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CLINICAL TRIAL; CONFORMATIONAL TRANSITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; MEMBRANE FUSION; NONHUMAN; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR SENSITIVITY; VIRUS ENVELOPE; VIRUS INHIBITION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANTI-HIV AGENTS; CELL LINE; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; NEVIRAPINE; PEPTIDE FRAGMENTS; RECEPTORS, CCR5; RECEPTORS, CXCR4; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 0034890660     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.18.8605-8614.2001     Document Type: Article

References (39)

1. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease
2. HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 co-receptor
3. CCR5 binds multiple CCchemokines: MCP-3 acts as a natural antagonist
4. Core structure of gp41 from the HIV envelope glycoprotein
5. HIV entry and its inhibition
6. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection
7. Expression cloning of new receptors used by simian and human immunodeficiency viruses
8. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120
9. Use of a gp120 binding assay To dissect the requirements and kinetics of human immunodeficiency virus fusion events
10. Identification of CXCR4 domains that support coreceptor and chemokine receptor functions
11. Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity
12. Capture of an early fusion-active conformation of HIV-1 gp41
13. A biosensor assay for studying ligand-membrane receptor interactions: Binding of antibodies and HIV-1 env to chemokine receptors
14. HIV-1 envelope determinants for cell tropism and chemokine receptor use
15. Analysis of the critical domain in the V3 loop of human immunodeficiency virus type 1 gp120 involved in CCR5 utilization
16. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1
17. Standardized microtiter assay for determination of syncytium-inducing phenotypes of clinical human immunodeficiency virus type 1 isolates
18. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry
19. Inhibition of HIV-1 entry before gp41 folds into its fusion-active conformation
20. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
21. A trimeric structural domain of the HIV-1 transmembrane glycoprotein
22. Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion
23. Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41
24. Mapping genetic determinants for human immunodeficiency virus type 1 resistance to soluble CD4
25. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain
26. Anti-human immunodeficiency virus type 1 activity of an oligocationic compound mediated via gp120 V3 interactions
27. Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides
28. Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene
29. Endocytosis and recycling of the HIV coreceptor CCR5
30. Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop
31. Atomic structure of a thermostable subdomain of HIV-1 gp41
32. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
33. Identification of the envelope V3 loop as a determinant of a CD4-negative neuronal cell tropism for HIV-1
34. Atomic structure of the ectodomain from HIV-1 gp41
35. Macrophage tropism determinants of humart immunodeficiency virus type 1 in vivo
36. Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex
37. A synthetic peptide inhibitor of human immunodeficiency virus replication: Correlation between solution structure and viral inhibition
38. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection
39. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5